Today's Date
Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m
(
)
ITN Protocol #:
ITN002AI
Branded Name:
ClinicalTrials.Gov ID:
NCT0009438Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
Clinical Operations Manager
ITN Biologist
NIAID Project Manager
Study Personnel:
